» Articles » PMID: 9365294

Environmental Tobacco Smoke Exposure and Ischaemic Heart Disease: an Evaluation of the Evidence

Overview
Journal BMJ
Specialty General Medicine
Date 1997 Nov 20
PMID 9365294
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To estimate the risk of ischaemic heart disease caused by exposure to environmental tobacco smoke and to explain why the associated excess risk is almost half that of smoking 20 cigarettes per day when the exposure is only about 1% that of smoking.

Design: Meta-analysis of all 19 acceptable published studies of risk of ischaemic heart disease in lifelong non-smokers who live with a smoker and in those who live with a non-smoker, five large prospective studies of smoking and ischaemic heart disease, and studies of platelet aggregation and studies of diet according to exposure to tobacco smoke.

Results: The relative risk of ischaemic heart disease associated with exposure to environmental tobacco smoke was 1.30 (95% confidence interval 1.22 to 1.38) at age 65. At the same age the estimated relative risk associated with smoking one cigarette per day was similar (1.39 (1.18 to 1.64)), while for 20 per day it was 1.78 (1.31 to 2.44). Two separate analyses indicated that non-smokers who live with smokers eat a diet that places them at a 6% higher risk of ischaemic heart disease, so the direct effect of environmental tobacco smoke is to increase risk by 23% (14% to 33%), since 1.30/1.06 = 1.23. Platelet aggregation provides a plausible and quantitatively consistent mechanism for the low dose effect. The increase in platelet aggregation produced experimentally by exposure to environmental tobacco smoke would be expected to have acute effects increasing the risk of ischaemic heart disease by 34%.

Conclusion: Breathing other people's smoke is an important and avoidable cause of ischaemic heart disease, increasing a person's risk by a quarter.

Citing Articles

Association of anthropometric variables with therapy-induced cardiotoxicity in women with breast cancer: a pilot study for a randomized clinical trial.

Merolillo K, Solari M, Cohen T, Lutz A, de Carvalho P, Canellas F Cardiooncology. 2024; 10(1):57.

PMID: 39252141 PMC: 11384697. DOI: 10.1186/s40959-024-00258-6.


Differences in Risk Factors for Coronary Atherosclerosis According to Sex.

Kim H J Lipid Atheroscler. 2024; 13(2):97-110.

PMID: 38826179 PMC: 11140242. DOI: 10.12997/jla.2024.13.2.97.


A systematic review of second-hand smoking mass media campaigns (2002-2022).

Lim C, Rutherford B, Gartner C, McClure-Thomas C, Foo S, Su F BMC Public Health. 2024; 24(1):693.

PMID: 38438990 PMC: 10913644. DOI: 10.1186/s12889-024-18222-5.


Health effects associated with exposure to secondhand smoke: a Burden of Proof study.

Flor L, Anderson J, Ahmad N, Aravkin A, Carr S, Dai X Nat Med. 2024; 30(1):149-167.

PMID: 38195750 PMC: 10803272. DOI: 10.1038/s41591-023-02743-4.


Assessing exposure to secondhand smoke among Iranian patients with cardiac diseases; a cross-sectional study.

Janjani H, Motevaseli S, Salehi N, Naseri S, Fazlzadeh M, Janjani P Heliyon. 2023; 9(11):e22715.

PMID: 38034752 PMC: 10687274. DOI: 10.1016/j.heliyon.2023.e22715.